Related Experiment Video
Updated: Mar 13, 2026
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma
Nathan B Roberts1, Aniket S Wadajkar1, Jeffrey A Winkles2
1Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA; Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD, USA.
Abstract:
Glioblastoma (GBM) is a fatal brain cancer for which new treatment options are sorely needed. Platinum-based drugs have been investigated extensively for GBM treatment but few have shown significant efficacy without major central nervous system (CNS) and systemic toxicities. The relative success of platinum drugs for treatment of non-CNS cancers indicates great therapeutic potential when effectively delivered to the tumor region(s). New insights into the broad anticancer effects of platinum drugs, particularly immunomodulatory effects, and innovative delivery strategies that can maximize these multi-modal effects and minimize toxicities may promote the re-purposing of this chemotherapeutic drug class for GBM treatment.
Insights
Platinum drugs show promise for treating glioblastoma (GBM), a fatal brain cancer. Innovative delivery strategies could enhance their anticancer effects and reduce toxicities, offering new hope for GBM patients.
Area of Science:
- Neuro-oncology
- Cancer Pharmacology
- Drug Delivery Systems
Background:
- Glioblastoma (GBM) is an aggressive brain cancer with limited treatment options.
- Platinum-based chemotherapy has shown efficacy in other cancers but faces challenges in GBM due to toxicity and delivery.
- Understanding the immunomodulatory effects of platinum drugs is crucial for novel therapeutic strategies.
Approach:
- Investigating platinum-based drugs for glioblastoma treatment.
- Exploring innovative drug delivery strategies to target brain tumors.
- Analyzing the immunomodulatory and anticancer effects of platinum compounds.
Key Points:
- Platinum drugs possess broad anticancer activities, including immunomodulation, relevant for glioblastoma.
- Effective delivery systems are essential to maximize therapeutic benefits and minimize central nervous system (CNS) and systemic toxicities.
- Repurposing platinum drugs may offer a viable new treatment avenue for GBM.
Conclusions:
- Platinum-based chemotherapy holds therapeutic potential for glioblastoma.
- Optimized delivery strategies are key to overcoming toxicity and efficacy challenges.
- Further research into platinum drug mechanisms and delivery is warranted for GBM treatment.
More Related Videos
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
Related Concept Videos
02:56Treatment Resistant Cancers
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...